Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.17p
   
  • Change Today:
      0.030p
  • 52 Week High: 3.42
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 78,626
  • Market Cap: £9.04m
  • RiskGrade: 328

Balance Sheet

  £ (Millions) £ (Millions)
Balance Sheet 31-Dec-10 31-Dec-09
Non-Current Assets    
Property, Plant & Equipment 0.08 0.01
Intangible Assets 0.70 0.75
Investment Properties n/a n/a
Investments n/a n/a
Other Financial Assets n/a n/a
Other Non-Current Assets n/a n/a
  0.78 0.76
Current Assets    
Inventories n/a n/a
Trade & Other Receivables 1.18 1.36
Current Investments - Listed n/a n/a
Current Investments - Deposits n/a n/a
Current Investments - Unlisted n/a n/a
Cash at Bank & in Hand 15.59 22.53
Cash on Short Term Deposit n/a n/a
Other Current Assets n/a n/a
  16.77 23.89
     
Other Assets n/a n/a
Total Assets 17.55 24.64
     
Current Liabilities    
Trade & Other Payables 0.64 5.31
Borrowings 0.04 0.03
Finance Lease Obligations n/a n/a
Other Current Liabilities 0.14 0.80
  0.81 6.14
     
Net Current Assets en/a en/a
     
Non-Current Liabilities    
Borrowings 0.77 0.43
Finance Lease Obligations n/a n/a
Other Non-Current Liabilities n/a n/a
Provisions - Deferred Tax n/a n/a
Provisions - Other n/a n/a
  0.77 0.43
     
Other Liabilities n/a n/a
Total Liabilities 1.58 6.56
     
Net Assets 15.97 18.08
     
Share Capital 8.15 8.11
Share Premium Account 7.45 7.30
Other Reserves (3.22) (2.78)
Retained Earnings 3.59 5.45
  15.97 18.08
     
Minority Interests/Other Equity n/a n/a
Total Equity 15.97 18.08
  £ (Millions) £ (Millions)
Notes to Balance Sheet 31-Dec-10 31-Dec-09
Shareholders Funds - Equity en/a en/a
Shareholders Funds - Non Equity en/a en/a
  en/a en/a
     
Borrowing Analysis    
Borrowings Under 1 year n/a n/a
Due 1 - 2 years n/a n/a
Due 2 - 5 years n/a n/a
Due After 5 years n/a n/a
Due 1 - 5 years Unanalysed n/a n/a
Due After 1 year Unanalysed n/a n/a
Less: Borrowings in Other Creditors n/a n/a
Total Borrowings 0.81 0.46
     
Property, Plant & Equipment Analysis    
Property    
Cost/Value at Start of Year n/a n/a
Acquisitions n/a n/a
Additions n/a n/a
Disposals n/a n/a
Exchanges & Other Movements n/a n/a
Cost/Value at End of Year n/a n/a
     
Property Depreciation    
At Start of Year n/a n/a
Acquisitions n/a n/a
Provided During Year n/a n/a
Disposals n/a n/a
Exchange & Other Movements n/a n/a
Cost/Value at End of Year n/a n/a
     
Property Net Book Value n/a n/a
     
Other Fixed Assets    
Cost/Value at Start of Year n/a n/a
Acquisitions n/a n/a
Additions n/a n/a
Disposals n/a n/a
Exchange & Other Movements n/a n/a
Cost/Value at End of Year n/a n/a
     
Other Fixed Assets Deprecation    
At Start of Year n/a n/a
Acquisitions n/a n/a
Provided During Year n/a n/a
Disposals n/a n/a
Exchange & Other Movements n/a n/a
At End of Year n/a n/a
     
Other Fixed Assets Net Book Value n/a n/a
     
Total Property, Plant & Equipment Net Book Value n/a n/a

Key

* GAAP

a. Total fixed assets

b. Debtors due within and after one year

c. Includes trade and other payables

d. Includes non-current assets

e. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page